621 related articles for article (PubMed ID: 6331664)
1. Benzo(a)pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis.
Nakayama J; Yuspa SH; Poirier MC
Cancer Res; 1984 Sep; 44(9):4087-95. PubMed ID: 6331664
[TBL] [Abstract][Full Text] [Related]
2. Formation and persistence of DNA, RNA, and protein adducts in mouse skin exposed to pure optical enantiomers of 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyre ne in vivo.
Pelling JC; Slaga TJ; DiGiovanni J
Cancer Res; 1984 Mar; 44(3):1081-6. PubMed ID: 6198079
[TBL] [Abstract][Full Text] [Related]
3. Formation of benzo(a)pyrene/DNA adducts and their relationship to tumor initiation in mouse epidermis.
Ashurst SW; Cohen GM; Nesnow S; DiGiovanni J; Slaga TJ
Cancer Res; 1983 Mar; 43(3):1024-9. PubMed ID: 6297716
[TBL] [Abstract][Full Text] [Related]
4. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
Kulkarni MS; Anderson MW
Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174
[TBL] [Abstract][Full Text] [Related]
5. In vivo DNA adduct formation by benzo(a)pyrene in mouse and rat epidermal and dermal fibroblasts after topical application of an initiating dose of benzo(a)pyrene.
Alexandrov K; Rojas-Moreno M
Arch Geschwulstforsch; 1990; 60(5):329-40. PubMed ID: 2241509
[TBL] [Abstract][Full Text] [Related]
6. Benzo(e)pyrene-induced alterations in the binding of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene to DNA in Sencar mouse epidermis.
Smolarek TA; Baird WM; Fisher EP; DiGiovanni J
Cancer Res; 1987 Jul; 47(14):3701-6. PubMed ID: 3109730
[TBL] [Abstract][Full Text] [Related]
7. Immunoaffinity chromatography of carcinogen DNA adducts with polyclonal antibodies directed against benzo[a]pyrene diol-epoxide-DNA.
Tierney B; Benson A; Garner RC
J Natl Cancer Inst; 1986 Jul; 77(1):261-7. PubMed ID: 3459918
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay.
Poirier MC; Santella R; Weinstein IB; Grunberger D; Yuspa SH
Cancer Res; 1980 Feb; 40(2):412-6. PubMed ID: 7356524
[TBL] [Abstract][Full Text] [Related]
9. Dose-response relationships for the binding of benzo(a)pyrene metabolites to DNA and protein in lung, liver, and forestomach of control and butylated hydroxyanisole-treated mice.
Adriaenssens PI; White CM; Anderson MW
Cancer Res; 1983 Aug; 43(8):3712-9. PubMed ID: 6305492
[TBL] [Abstract][Full Text] [Related]
10. Similarities in the formation and removal of covalent DNA adducts in benzo(a)pyrene-treated BALB/3T3 variant cells with different induced transformation frequencies.
Lo KY; Kakunaga T
Cancer Res; 1982 Jul; 42(7):2644-50. PubMed ID: 6282445
[TBL] [Abstract][Full Text] [Related]
11. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by butylated hydroxyanisole.
Anderson MW; Boroujerdi M; Wilson AG
Cancer Res; 1981 Nov; 41(11 Pt 1):4309-15. PubMed ID: 6272975
[TBL] [Abstract][Full Text] [Related]
12. In vivo formation and persistence of DNA adducts in mouse and rat skin exposed to (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo[a]pyrene and (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.
Rojas M; Alexandrov K
Carcinogenesis; 1986 Sep; 7(9):1553-60. PubMed ID: 3091285
[TBL] [Abstract][Full Text] [Related]
13. Clotrimazole, an inhibitor of epidermal benzo(a)pyrene metabolism and DNA binding and carcinogenicity of the hydrocarbon.
Mukhtar H; Del Tito BJ; Das M; Cherniack EP; Cherniack AD; Bickers DR
Cancer Res; 1984 Oct; 44(10):4233-40. PubMed ID: 6088034
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of benzo(a)pyrene and benzo(a)pyrene-trans-7,8-diol metabolism and DNA binding in mouse lung explants by ellagic acid.
Dixit R; Teel RW; Daniel FB; Stoner GD
Cancer Res; 1985 Jul; 45(7):2951-6. PubMed ID: 4039974
[TBL] [Abstract][Full Text] [Related]
15. Expanded analysis of benzo[a]pyrene-DNA adducts formed in vitro and in mouse skin: their significance in tumor initiation.
Chen L; Devanesan PD; Higginbotham S; Ariese F; Jankowiak R; Small GJ; Rogan EG; Cavalieri EL
Chem Res Toxicol; 1996; 9(5):897-903. PubMed ID: 8828927
[TBL] [Abstract][Full Text] [Related]
16. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
Dreij K; Seidel A; Jernström B
Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
[TBL] [Abstract][Full Text] [Related]
17. Correlation between formation of a specific hydrocarbon-deoxyribonucleoside adduct and tumor-initiating activity of 7,12-dimethylbenz(a)anthracene and its 9- and 10-monofluoroderivatives in mice.
DiGiovanni J; Sawyer TW; Fisher EP
Cancer Res; 1986 Sep; 46(9):4336-41. PubMed ID: 3089589
[TBL] [Abstract][Full Text] [Related]
18. Analysis of benzo(a)pyrene:DNA adducts formed in cells in culture by immobilized boronate chromatography.
Pruess-Schwartz D; Sebti SM; Gilham PT; Baird WM
Cancer Res; 1984 Sep; 44(9):4104-10. PubMed ID: 6331665
[TBL] [Abstract][Full Text] [Related]
19. Effect of butylated hydroxyanisole, alpha-angelica lactone, and beta-naphthoflavone on benzo(alpha)pyrene:DNA adduct formation in vivo in the forestomach, lung, and liver of mice.
Ioannou YM; Wilson AG; Anderson MW
Cancer Res; 1982 Apr; 42(4):1199-204. PubMed ID: 7059996
[TBL] [Abstract][Full Text] [Related]
20. Products of binding of 7,12-dimethylbenz(a)anthracene to DNA in mouse skin.
Bigger CA; Sawicki JT; Blake DM; Raymond LG; Dipple A
Cancer Res; 1983 Dec; 43(12 Pt 1):5647-51. PubMed ID: 6315214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
